Karmanos Cancer Institute to Launch Health Initiative Focused on Environmentally-Associated Cancers

* Reuters is not responsible for the content in this press release.

Wed Oct 21, 2009 11:12am EDT

Karmanos Cancer Institute to Launch Health Initiative Focused on
Environmentally-Associated Cancers





DETROIT, Oct. 21 /PRNewswire-USNewswire/ -- The Barbara Ann Karmanos Cancer
Institute, in cooperation with Blue Cross Blue Shield of Michigan (BCBSM),
will launch a targeted health initiative in January 2010 focused on
environmentally-associated cancers. 


(Logo:  http://www.newscom.com/cgi-bin/prnh/20071106/KARMANOSLOGO )


By the end of this year, according to the American Cancer Society, it is
estimated that 1,479,350 new cases of cancer will be reported in this country.
According to Karmanos Interim President and CEO Ann G. Schwartz, Ph.D., MPH,
approximately 70 percent of all cancers are linked to occupational and
environmental causes, including tobacco use and diet, based on information
from the National Institutes of Health (1).


"A medical evidence-based approach will be presented to doctors participating
in BCBSM's Physician Group Incentive Program (PGIP) in early December," Dr.
Schwartz said.  "The initiative is being designed to detect cancers and other
serious illness resulting from exposure to arsenic and asbestos, two of the
state's most frequently encountered carcinogens."


Director and author of the initiative Michael Harbut, M.D., MPH, FCCP, of
Karmanos, an occupational and environmental medical expert, said that by
utilizing existing data that has identified workplace and environmental
arsenic and asbestos, "we can determine who is at risk, what preventive care
may be recommended and more accurately diagnose and treat those at risk
because of the water they drink or air they breathe."  


Dr. Harbut said that Karmanos "will offer this program to physicians to
accurately identify who is at risk for disease before symptoms become
apparent.  It is not unusual for people to be unaware that they have even been
exposed to these toxins."  


Asbestos and arsenic have been singled out because their impact continues to
take a serious health toll on Michigan's residents.  Michigan has the nation's
largest arsenic-contaminated water table, located primarily in the
southeastern part of the state, and an estimated 300,000 homes with
asbestos-contaminated attic insulation.


Even low levels of exposure to asbestos can cause asbestosis -- a potentially
fatal disease of the lungs -- as well as lung cancer and mesothelioma, an
extremely aggressive cancer of the covering of the lungs and intestines.
Smokers are 50 times more likely to develop lung cancer if they also are
exposed to asbestos.  In addition, colon cancer has been associated with
asbestos exposure. There is a latency period from time of first exposure to
clinical identification of disease of 15-40 years.  Contrary to popular
belief, asbestos has never been banned in the United States.


Note: (1) Cancer and the environment: What you need to know, what you can do
(2003).  NIH Publication No. 03-2039.


About the Barbara Ann Karmanos Cancer Institute 


Located in mid-town Detroit, Michigan, the Barbara Ann Karmanos Cancer
Institute is one of 40 National Cancer Institute-designated comprehensive
cancer centers in the United States. Caring for nearly 6,000 new patients
annually on a budget of $216 million, conducting more than 700 cancer-specific
scientific investigation programs and clinical trials, the Karmanos Cancer
Institute is among the nation's best cancer centers. Through the commitment of
1,000 staff, including nearly 300 faculty members, and supported by thousands
of volunteer and financial donors, the Institute strives to prevent, detect
and eradicate all forms of cancer. For more information call 1-800-KARMANOS or
go to www.karmanos.org.       




SOURCE  Barbara Ann Karmanos Cancer Institute

Patricia A. Ellis of the Barbara Ann Karmanos Cancer Institute,
+1-313-576-8629, +1-313-410-3417 (cell)
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.